Location of recurrent cardiovascular events and anticardiolipin antibodies.

Javier Galán-GonzálezSergio Rico-MartinJulián F Calderón-GarcíaJoaquín AntónJosé María Ramírez-MorenoLorenzo R Álvarez-RodríguezJuan F Sánchez Muñoz-Torreronull null

Published in: European journal of clinical investigation (2021)

Positivity of aCL antibodies is associated with an increased risk of subsequent distal artery ischaemic events (cerebral or leg arteries) but not coronary artery events. Anticardiolipin antibodies appear to have a different relationship on the localisation of ischaemic events in patients with symptomatic artery disease.

Keyphrases

cardiovascular events
coronary artery
coronary artery disease
cardiovascular disease
pulmonary artery
minimally invasive
subarachnoid hemorrhage
type diabetes
pulmonary hypertension
cerebral ischemia